However, recent studies on T CD8 + cancer infiltration indicate that the deficiency of tumor associated macrophages (TAMs) positive for TREM2 is associated with a stronger cytotoxic T cell activity and a higher responsivity to anti PD-1 immunotherapy (35) (36). This evidence concerns the gene TREM2 and cancer.